Charles Bonnet Syndrome Treated With Pimavanserin

被引：2

作者：

Boren, Rance A. ^{[1
]}

Boren, Carol B. ^{[1
]}

机构：

[1] CRB Med Associates, Brownwood, TX USA

来源：

JOURNAL OF NEURO-OPHTHALMOLOGY | 2019年 / 39卷 / 04期

关键词：

VISUAL HALLUCINATIONS; ESCITALOPRAM;

D O I：

10.1097/WNO.0000000000000800

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：500 / 501

页数：2

共 8 条

[1] Serotonin 2A Receptors and Visual Hallucinations in Parkinson Disease [J].

Ballanger, Benedicte ;

Strafella, Antonio P. ;

van Eimeren, Thilo ;

Zurowski, Mateusz ;

Rusjan, Pablo M. ;

Houle, Sylvain ;

Fox, Susan H. .

ARCHIVES OF NEUROLOGY, 2010, 67 (04) :416-421

[2] Successful Use of Escitalopram for the Treatment of Visual Hallucinations in Patients With Parkinson Disease [J].

Bergman, Joseph ;

Lerner, Paul P. ;

Sokolik, Shmuel ;

Lerner, Vladimir ;

Kreinin, Anatoly ;

Miodownik, Chanoch .

CLINICAL NEUROPHARMACOLOGY, 2017, 40 (06) :246-250

[3] Escitalopram for antipsychotic nonresponsive visual hallucinosis: eight patients suffering from Charles Bonnet syndrome [J].

Bergman, Yoseph ;

Barak, Yoram .

INTERNATIONAL PSYCHOGERIATRICS, 2013, 25 (09) :1433-1436

[4] Complex visual hallucinations Clinical and neurobiological insights [J].

Manford, M ;

Andermann, F .

BRAIN, 1998, 121 :1819-1840

[5]

Mocellin R, 2006, AUST NZ J PSYCHIAT, V40, P742

[6] mRNA expression profile of serotonin receptor subtypes and distribution of serotonergic terminations in marmoset brain [J].

Shukla, Rammohan ;

Watakabe, Akiya ;

Yamamori, Tetsuo .

FRONTIERS IN NEURAL CIRCUITS, 2014, 8

[7] Mechanism of action of pimavanserin in Parkinson's disease psychosis: targeting serotonin 5HT2A and 5HT2C receptors [J].

Stahl, Stephen M. .

CNS SPECTRUMS, 2016, 21 (04) :271-275

[8]

Velakoulis D, 2016, GENOMICS, CIRCUITS, AND PATHWAYS IN CLINICAL NEUROPSYCHIATRY, P375, DOI 10.1016/B978-0-12-800105-9.00024-X

← 1 →